Sam Shuster

Title: Sam Shuster: Innovator in Dermatological Solutions

Introduction

Sam Shuster is a notable inventor based in Newcastle Upon Tyne, GB. He has made significant contributions to the field of dermatology through his innovative patent. His work focuses on improving the treatment experience for patients using anthralin, a medication commonly used for skin conditions.

Latest Patents

Sam Shuster holds a patent for a method of reducing anthralin-induced inflammation and staining. This lenitive composition is designed for application to the skin of anthralin patients to alleviate inflammation and staining associated with its use. The composition is a single-phase aqueous treating solution that includes an organic amine and a film-forming agent, all dissolved within a nontoxic dermatologically acceptable carrier. The organic amine is selected from a group of lower alkyl and lower alkanol primary, secondary, and tertiary amines, comprising about 1 to 25 percent by weight of the solution. This solution is applied topically to the anthralin-treated areas, preferably in the form of a fine spray or mist.

Career Highlights

Sam Shuster is associated with Young Pharmaceuticals, Inc., where he continues to develop innovative solutions for dermatological applications. His work has been instrumental in enhancing patient care and comfort during anthralin treatment.

Collaborations

Some of his notable coworkers include John E Kuleza and Lawrence Clifford M. Their collaborative efforts contribute to the advancement of dermatological treatments and innovations.

Conclusion

Sam Shuster's contributions to dermatology through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the field positively, making a significant impact on the treatment of skin conditions.